Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Urology : Official Journal of the Japanese Urological Association|May 12, 2026
Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA StudyHiroki Shimoda, Yuki Nakamura, Masaharu Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 8, 2026
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying EffectsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Urology and Nephrology|April 21, 2026
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinationsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
Urologic Oncology|September 3, 2025
Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary systemMargaret F Meagher, Giacomo Musso, Viraj Master, et al.
Urology|June 27, 2025
Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive ModelingGiacomo Musso, Natalie Birouty, Andrea Salonia, et al.
Clinical Genitourinary Cancer|May 11, 2024
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC RegistryCesare Saitta, Jonathan A Afari, Dattatraya Patil, et al.
Urologic Oncology|April 22, 2025
Paraneoplastic and symptomatic score (PRIMAL) for prediction of overall and cancer-specific survival after surgery in patients with renal cell carcinomaGiacomo Musso, Margaret F Meagher, Kit L Yuen, et al.
Clinical Genitourinary Cancer|July 7, 2024
Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) RegistryJulian A Cortes, Cesare Saitta, Kit L Yuen, et al.
Clinical Genitourinary Cancer|October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell CarcinomaCesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
Pageof 8